BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32450313)

  • 1. Meta-Analysis with Trial Sequential Analysis on the Efficacy and Safety of Erythropoietin in Traumatic Brain Injury: A New Paradigm.
    Katiyar V; Chaturvedi A; Sharma R; Gurjar HK; Goda R; Singla R; Ganeshkumar A
    World Neurosurg; 2020 Oct; 142():465-475. PubMed ID: 32450313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of erythropoietin in patients with traumatic brain injury: a meta-analysis of randomized controlled trials.
    Liu WC; Wen L; Xie T; Wang H; Gong JB; Yang XF
    J Neurosurg; 2017 Jul; 127(1):8-15. PubMed ID: 27367243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of erythropoietin for traumatic brain injury.
    Liu M; Wang AJ; Chen Y; Zhao G; Jiang Z; Wang X; Shi D; Zhang T; Sun B; He H; Williams Z; Hu K
    BMC Neurol; 2020 Nov; 20(1):399. PubMed ID: 33138778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Efficacy of Erythropoietin on Reducing the Risk of Mortality in Patients with Traumatic Brain Injury: A Systematic Review and Meta-Analysis.
    Liu C; Huang C; Xie J; Li H; Hong M; Chen X; Wang J; Wang J; Li Z; Wang J; Wang W
    Biomed Res Int; 2020; 2020():7563868. PubMed ID: 33178833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of erythropoietin in patients with traumatic brain injury: A systematic review and meta-analysis.
    Lee J; Cho Y; Choi KS; Kim W; Jang BH; Shin H; Ahn C; Lim TH; Yi HJ
    Am J Emerg Med; 2019 Jun; 37(6):1101-1107. PubMed ID: 30220640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin in patients with traumatic brain injury and extracranial injury-A post hoc analysis of the erythropoietin traumatic brain injury trial.
    Skrifvars MB; Bailey M; French C; Presneill J; Nichol A; Little L; Duranteau J; Huet O; Haddad S; Arabi Y; McArthur C; Cooper DJ; Bellomo R;
    J Trauma Acute Care Surg; 2017 Sep; 83(3):449-456. PubMed ID: 28590358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.
    Robinson S; Winer JL; Berkner J; Chan LA; Denson JL; Maxwell JR; Yang Y; Sillerud LO; Tasker RC; Meehan WP; Mannix R; Jantzie LL
    J Neurosurg Pediatr; 2016 Jun; 17(6):739-55. PubMed ID: 26894518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does erythropoietin affect the outcome and complication rates of patient with traumatic brain injury? A pooled-analysis.
    Li Y; Zhang J; Wang H; Zhu L; Zhang H; Ma Q; Liu X; Dong L; Lu G
    Neurol Sci; 2022 Jun; 43(6):3783-3793. PubMed ID: 35044560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Erythropoietin in Traumatic Brain Injury: A Multinational Trial-Based Economic Analysis.
    Knott RJ; Harris A; Higgins A; Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars MB; Vallance S; Varma D; Wills J; Bellomo R
    J Neurotrauma; 2019 Sep; 36(17):2541-2548. PubMed ID: 30907230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of erythropoietin in treating experimental traumatic brain injury: a systematic review of controlled trials in animal models.
    Peng W; Xing Z; Yang J; Wang Y; Wang W; Huang W
    J Neurosurg; 2014 Sep; 121(3):653-64. PubMed ID: 25036201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury.
    Skrifvars MB; Luethi N; Bailey M; French C; Nichol A; Trapani T; McArthur C; Arabi YM; Bendel S; Cooper DJ; Bellomo R;
    Intensive Care Med; 2023 Jul; 49(7):831-839. PubMed ID: 37405413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
    Wilson J; Yao GL; Raftery J; Bohlius J; Brunskill S; Sandercock J; Bayliss S; Moss P; Stanworth S; Hyde C
    Health Technol Assess; 2007 Apr; 11(13):1-202, iii-iv. PubMed ID: 17408534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.
    Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars M; Vallance S; Varma D; Wills J; Bellomo R; ;
    Lancet; 2015 Dec; 386(10012):2499-506. PubMed ID: 26452709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative safety of multiple doses of erythropoietin for the treatment of traumatic brain injury: A systematic review and network meta-analysis.
    Zheng Q; Duan D; Xu J; Wang X; Ge Y; Xiong L; Yang J; Wulayin S; Luo X
    Front Neurol; 2022; 13():998320. PubMed ID: 36582613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: A brief report on the Australian EPO-TBI clinical trial.
    Hellewell SC; Conquest A; Little L; Vallance S; Board J; Bellomo R; Cooper DJ; Morganti-Kossmann MC
    J Clin Neurosci; 2020 Jun; 76():5-8. PubMed ID: 32331937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin in perinatal hypoxic-ischemic encephalopathy: a systematic review and meta-analysis.
    Razak A; Hussain A
    J Perinat Med; 2019 May; 47(4):478-489. PubMed ID: 30789826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin in traumatic brain injury associated acute kidney injury: A randomized controlled trial.
    Skrifvars MB; Moore E; Mårtensson J; Bailey M; French C; Presneill J; Nichol A; Little L; Duranteau J; Huet O; Haddad S; Arabi Y; McArthur C; Cooper DJ; Bellomo R;
    Acta Anaesthesiol Scand; 2019 Feb; 63(2):200-207. PubMed ID: 30132785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin treatment in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Gao D; Ning N; Niu X; Dang Y; Dong X; Wei J; Zhu C
    Am Heart J; 2012 Nov; 164(5):715-727.e1. PubMed ID: 23137502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004863. PubMed ID: 22972076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.